Ocular Nanotechnology Tasiwent n uqeṛṛu n tɣult sɣur Cynthia Turner d anerbaz yettwaqadren meqqren n 2024 Tarbaḥt A' Design Award n Uzzal deg Taggayt n Tnaflit n Afeṣṣel n Unuɣ Aselkiman, Asnulfu 3D, Aɣummu d Usiẓreg.
UzzalUnuɣ Aselkiman· 2024
Ocular Nanotechnology Tasiwent n uqeṛṛu n tɣult
sɣur Cynthia Turner
Amsaɣ: Alexander and Turner Medical Illustration Studio
Anerbaz n Tarbaḥt A' Design Award n Uzzal deg Taggayt n Unuɣ Aselkiman
Anerbaz n Urraz Yettwasenqden
Senqed Addad n Urraz i #154797Afeṣṣel
Ɣef Ocular Nanotechnology Tasiwent n uqeṛṛu n tɣult
Am ilugan seg umaḍal-nniḍen, timecṭuḥin-a n usiwḍen sserwayent-aɣ-d s waṭas n telɣiwin d tneɣruft-nsent, daɣen s teɛlaqt-nsent akked twennaḍt n waman anda tzemrent ad tiniɣent s tfeɛqilt akken ad awint ayen i tent-id-yettwaǧǧan ɣer wadeg ameɣtu. Tinanoparticules d timecṭuḥin tigejdanin imeẓẓyanen i usegfer n wallen acku ttemɛaǧǧint d tudert tasnalɣayt u tzemrent ad ttwarnint s isigimen d tmusniwin tijinetikin s uqqen akimiyan, asekcem, neɣ asekruḍ deg umeswiḍ nano. S tuzzya seg tizi n tfesna: nanopolymère, nanoémulsion, nanomicelle, d liposome.
Asmekti
Ɣef Tarbaḥt A' Design Award n Uzzal
Ocular Nanotechnology Tasiwent n uqeṛṛu n tɣult d amerbaḥ n Tarbaḥt A' Design Award n Uzzal, tagmat i yisnulfa yelhan i yemmalen ayen i d-ttrajun yimdanen seg yisnulfa yelhan. Imerbaḥen n Uzzal ttbanen d tmusni, tmahilt d tazmert n yimahilen-nsen. Ocular Nanotechnology Tasiwent n uqeṛṛu n tɣult ad yili d asnulfu yettwaɛezzen, yelhan, amaynut. Isnulfa-a ttwaɛezzen imi ɛawnen deg tudert, rran ddunit ugar n lxir.
Deffir n ufeṣṣel
Tagrurt n tɣamsa
Ismawen n terbaɛt, iferdisen itiknikanen akked telɣut i d-yefka umeṣṣufeɣ.
- Taɣara Tasuft
- Nanoparticles are 1 to 100 nanometres in diameter and have unique properties due to their small size and high surface area to volume ratio. Nanoparticles are the most common nanocarriers for ocular therapeutics due to their biocompatibility and their capacity to be loaded with drugs and gene therapies by chemical attachment, embedment, or encapsulation in the nanocarrier. Highlighting four types of nanotechnology-based ocular drug delivery systems delivering their payloads to the back of the eye, clockwise starting at noon: nanopolymer, nanoemulsion, nanomicelle, and liposome.
- Tigejdiwin & Akemmus
- Width 431.8 mm width x Height 279.4 mm, 300 dpi, tiff
- Tibzimin
- medical illustration, biomedical artist, visual science, ophthamology, nanocarriers, ocular drug delivery
- Tasnakta n Ufares
- Created using Cinema 4D, a 3D modeling program, 3D Models, and hand-painting in Photoshop, using a stylus and tablet on a Mac.
- Asewḥel n Usnulfu
- Create accurate depictions of ocular drug delivery nanocarriers and arrange the four carriers in a pleasing composition that did not necessarily give one precedence in importance over another.
- Anadi
- The artist researched the morphology of the 4 specified nanocarriers and created accurate scientific visualizations of them. Each nanocarrier was separately modeled and imaged in a 3D program, and then brought into a Photoshop document. The composited tiff was finished by handpainting in Photoshop to reflect light from one element to the next to bring color harmony to the palette. Additional motion elements were painted to tie the composition together and lead the eye in reading the image.
- Aseḥbiber
- An illustration for the cover of EyeNet, the magazine of the American Academy of Ophthalmology, for their annual meeting and special annual issue. I created the nanocarriers individually in Cinema4D, a 3D software program, and then composed them in Photoshop on a background of a field of the rods and cones cells found at the back of the eye. I enhanced the rendered 3D models by reflecting the colors from one into the other, and creating light effects to add movement and excitement to the composition.
- Tanzagt n Usenfar
- The project was in development for two weeks at the artist's studio in Santa Rosa Beach, Florida, USA.
- Tanila n Umahil
- The Art Director requested an illustration with a science fiction futuristic feel to be used for their special annual issue, which is also released on the occasion of the American Academy of Ophthalmology's annual meeting and is used to brand the meeting.
- Ibrivan
- Copyrights belong to Cynthia Turner, 2023
- Imsuren n Tugniwin
- Image #1: Illustrator Cynthia Turner / Alexander and Turner Medical Illustration Studio / Ocular Nanotechnology, 2023
Image #2: Illustrator Cynthia Turner / Alexander and Turner Medical Illustration Studio / Ocular Nanotechnology, 2023
Image #3: Illustrator Cynthia Turner / Alexander and Turner Medical Illustration Studio / Ocular Nanotechnology, 2023
Image #4: Illustrator Cynthia Turner / Alexander and Turner Medical Illustration Studio / Ocular Nanotechnology, 2023
Image #5: Illustrator Cynthia Turner / Alexander and Turner Medical Illustration Studio / Ocular Nanotechnology, 2023
Yettwaxellṣen
Snirem Seld Designers.org
Af-d iferdisen, imeẓla d tegnatin sɣur yimɛawnen-nneɣ n usissen.
Ugar i tifin
Ifeṣṣelen yemcudden
Snirem ugar n ifeṣṣelen yewwin ammud seg twennaḍt-nni kan, ttwaferzent s lmeɛna.
